On April 08, 2022 BeyondSpring Inc. (the "Company" or "BeyondSpring") (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, reported that it will report its financial results for the quarter and year ended December 31, 2021 before market open on Thursday, April 14, 2022 (Press release, BeyondSpring Pharmaceuticals, APR 8, 2022, View Source;utm_medium=rss&utm_campaign=beyondspring-to-announce-fourth-quarter-and-year-end-2021-financial-results-and-host-a-conference-call-on-thursday-april-14-2022 [SID1234611660]). Management will also host a conference call with investors to discuss financial results and provide a corporate update at 8:00 am Eastern Time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!